Viral Hepatitis
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jan 28, 2005; 11(4): 488-491
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.488
Table 1 Distribution of autoantibodies in chronic hepatitis C patients.
AutoantibodiesPatients, total (n = 90) n%Males (n = 58) n%Females (n = 32) n%
ANA 1:1012 (13.3)8 (13.8)4 (12.5)
ANA 1:1001 (1.1)1 (1.7)0 (0)
SMA 1:1034 (37.8)25 (43.1)9 (28.1)
SMA 1:1005 (5.5)4 (6.9)1 (3.1)
ANA+SMA9 (10.0)7 (12.1)2 (6.3)
ARA 1:1001 (1.1)1 (1.7)0 (0)
TMA 1:101 (1.1)01 (3.1)
TMA 1:1001 (1.1)01 (3.1)
Total46 (51.1)32 (55.2)14 (43.7)
Table 2 Comparison of distribution of HCV genotypes among patients positive for different autoantibodies and between sex groups.
Total (n = 90) n(%)1b (n = 66) n(%)3a (n = 18) n(%)2a (n = 6) n (%)Men (n = 58) n(%)Women (n = 32)n (%)
ANA13 (14.4)10 (15.2)2 (11.1)1 (16.6)8 (13.8)5 (15.6)
SMA39 (43.3)30 (45.5)8 (44.4)1 (16.6)29 (50.0)10 (31.3)
TMA2 (2.2)2 (3.0)---2 (6.3)
ARA1 (1.1)-1 (5.6)-1 (1.7)-
Total46 (51.1)37 (56.1)9 (50.0)1 (16.6)32 (55.2)14 (43.8)